Results: Patients with mild, moderate, and severe symptoms who received curcumin/piperine treatment showed early symptomatic recovery (fever, cough, sore throat, and breathlessness), less deterioration, fewer red flag signs, better ability to maintain oxygen saturation above 94% on room air, and better clinical outcomes compared to patients of the control group. Furthermore, curcumin/piperine treatment appeared to reduce the duration of hospitalization in patients with moderate to severe symptoms, and fewer deaths were observed in the curcumin/piperine treatment group.
Conservative. Idaho. Software engineer. Historian. Trying to prevent Idiocracy from becoming a documentary.
Email complaints/requests about copyright infringement to clayton @ claytoncramer.com. Reminder: the last copyright troll that bothered me went bankrupt.
Friday, December 17, 2021
Frontiers in Pharmacology
Peer reviewed randomized clinical trial:
Subscribe to:
Post Comments (Atom)
Makes sense.
ReplyDeleteCurcumin is anti-inflamatory:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572027/
And there's plenty of evidence that SARS-COV-2 causes inflamation, including in fat cells.
Well, that explains the four different Turmeric delivery systems I've seen in the vitamins and minerals section of Costco.
ReplyDelete